A dementia-focused VC digs past anti-amyloid for neuroscience diamonds in the rough

Even as new drugs like Eisai and Biogen’s Leqembi make a splash in Alzheimer’s, VCs like the Dementia Discovery Fund have invested in the next wave of therapies.